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VALIDATING LIKERT-TYPE MEASURES USING NONPARAMETRIC AND 
PARAMETRIC ITEM RESPONSE THEORY
Lin HW1, Pickard AS2, Karabatsos G3, Mahady GB2, Crawford SY2, Popovich NG2
1China Medical University, Taichung, Taiwan, 2College of Pharmacy, University of Illinois at
Chicago, Chicago, IL, USA, 3College of Education, University of Illinois at Chicago, Chicago, IL, 
USA
OBJECTIVES: Item response theory (IRT) is one of measurement models used for
evaluation of the quality of rating scale measures in health outcomes research. Kernel 
regression on item response theory (KIRT) is a nonparametric IRT alternative to
common approaches derived from the classical test theory and parametric IRT (e.g.,
Rasch) models. The objectives of this study were to identify and compare the agree-
ment and discrepancy in item quality assessment using nonparametric and parametric 
IRT. METHODS: KIRT and Rasch approaches were utilized to examine psychometric
properties towards Likert-type measures assessing pharmacists’ performance of 
patient counseling in general (PC-G) and counseling on herbs and dietary supplements 
(PC-HDS), in a large-scale validation study. Agreement and discrepancy of item
performance assessment were examined based on the underlying attributes of 
models, corresponding analysis techniques and assessment criteria (e.g., examining 
violations of unidimentional psychometric theory assumptions for KIRT, examining 
the undesired discrepancy between observed and model expected values for Rasch 
model). RESULTS: Seven out of 10 PC-G items (70%) and six out of seven PC-HDS
items (86%) were good quality items based on both approaches. Two good quality 
items in the KIRT model did not ﬁ t the Rasch model well (i.e., outﬁ t ZSTD „d „n„b 
2„n), whereas the three good ﬁ tting items in the Rasch model were recognized as poor
quality items in the KIRT model (violated monotonicity or local independence).
CONCLUSIONS: There was fair amount of agreement between the two approaches
with retrospect to validate performance measures. The discrepancy of two approaches
resulted from the differences between corresponding measurement models and the 
pre-speciﬁ ed criteria for quality assessment. In particular, the KIRT tended to identify
poor quality items that didn’t intuitively match unidimentional psychometric proper-
ties, but the Rasch approach tended to identify poor quality items which might belong
to a second construct.
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FACTORS AFFECTING CHOICE OF ANTIBIOTIC USE IN ACUTE
BACTERIAL RESPIRATORY TRACT INFECTIONS: A SURVEY IN THAI
PHYSICIANS
Piyavetvirat K1, Leartsakulpanitch J2
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OBJECTIVES: To examine physicians’ attitude towards factors and their relative
importance affecting antibiotic prescribing for ambulatory adult patients with acute 
bacterial RTIs:; acute rhinosinusitis (R), community acquired pneumonia (CAP), phar-
yngitis (P), exacerbation of chronic bronchitis (B). METHODS: The Internal medicine,
ENT, Chest medicine, and Infectious physicians were selected to be our respondents. 
Based on a list of registered medical practitioners we only selected those who worked
in Bangkok (251 physicians). During August- September 08, we went to see them at
their practice settings and asked them to participate in the study. Finally, there were
only 121 physicians who participated in our survey. RESULTS: Total respondents were
internal medicine (28.9%), ENT (27.3%), Chest medicine (26.4%), and infectious 
(17.4%). Most of them were male (74.4%) and worked in private hospitals (53.7%).
Among the 4 diseases, they reported that the highest volume of patients were seen in
the P, followed by R, B, and CAP. Drug efﬁ cacy was reported to be the most important 
factor affecting the physicians’ decision on antibiotic choice across all specialties, fol-
lowed by disease severity, drug side effect, total treatment cost, and ease of use,
respectively (mean rank  1.28, 2.64, 3.60, 5.31, 5.44). Drug resistance and experience 
of use were viewed similarly as the subsequent imperative aspects for antibiotic selec-
tion (mean rank  5.7 and 5.8). CONCLUSIONS: In acute bacterial RTIs, the drug
efﬁ cacy and disease severity were found to be the most important factors affecting the 
physicians’ choice of antibiotic, whereas drug resistance was reported less signiﬁ cant.
To ensure effective use of antibiotic in acute bacterial RTIs infection, the drug knowl-
edge and evidence in varied severity stages are essential, the local recent data on drug
resistance should be more well noted for practicing physician in order to increase their 
awareness on this issue.
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DRUG UTILIZATION PATTERNS AND COSTS OF ANTIBIOTIC THERAPY
AMONG PATIENTS WITH OR WITHOUT CANCER IN A 2000-BED
MEDICAL CENTER IN TAIWAN
Lin HW, Yao SH, Huang HC
China Medical University, Taichung, Taiwan
OBJECTIVES: Inappropriate antibiotic consumptions in hospitals persists as one of 
patient safety concerns in Taiwan despite many efforts and health policies to address 
this problem. We performed a secondary data analysis to describe and compare the 
utilization and cost of systematic antibiotic therapy in the management of infections
among patients with (CApt) or without cancer (NCApt) for quality improvement of 
medical care. METHODS: The claim data of antibiotic prescription and correspond-
ing cost from the 2000-bed medical center afﬁ liated to a medical university in Taiwan 
were analyzed. Examining the trends and differences of antibiotic cost among CApt
and NCApt during hospitalizations in years of 2005 and 2006, the 95% conﬁ dence 
intervals of antibiotic cost and relative weight of diagnosis-related group for NCApt 
were compared monthly. In the ﬁ rst half of year 2007, the months with average cost 
of antibiotics greater than the breakpoint, which was derived from the prior two-year
analysis, were selected to further identify the principle diagnoses and antibiotics 
needed to have special attention. RESULTS: There were statistically signiﬁ cant higher 
average antibiotic costs of CApt than of NCApt in July, August and October, 2005
and in January, April, May and July, 2006. Given the NTD 15,500 (USD  ^455) was 
recognized as breakpoint of average antibiotic cost for cancer patients in 2007, visits 
hospitalized in May due to receiving radiotherapy, chemotherapy, management for 
acute myeloid leukemia, cervical cancer and so on should be paid more attention on 
infection management. Ten parenteral antibiotics (e.g., Tazocin, Targocid), accounted 
for 89.64% of total antibiotic costs in May, were selected for rigorous controlled dis-
pensations in the second half of year 2007 and later. CONCLUSIONS: Sustained 
control efforts focusing on those visits receiving radio- and chemo-therapy and/or
using speciﬁ c extend spectrum antibiotics during hospitalizations are necessary to 
improve antibiotic use and infection control in hospitals.
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SMOKING CESSATION AND ITS PREDICTORS: RESULTS FROM
COMMUNITY BASED PHARMACY TOBACCO CESSATION PROGRAM
IN NEW MEXICO
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OBJECTIVES: 1) To assess tobacco quit rates among a convenient sample of current 
smokers who participated in the community pharmacist-based program, and 2) to
identify the predictors of quitting over a 6-month period among the study population.
METHODS: Each year approximately 200 patients were enrolled across 15 pharma-
cies throughout New Mexico. Pharmacists, who had received the Rx for Change
training, provided the cessation program with administrative and clerical support from 
the Pharmacy Technicians. Patients were provided counseling services at no charge
and, if necessary, received medications without charge. Patients did not receive any 
monetary compensation for participation. Data on patient’s demographic information, 
smoking status, and readiness for quitting was collected at the initial enrollment. Data
on smoking status was collected at 1, 3, and 6 months. Statistical Analysis: Missing
data on follow-up was imputed using the last observation carry forward method. 
Smoking cessation rates were calculated at 1, 3, and 6 months. Multiple Logistic 
regression analysis was performed to assess predictors of quitting. Standard errors 
were adjusted for repeated observation. RESULTS: Final sample size was 346 partici-
pants. The average quit rate at the end of 6 months was 25%. Signiﬁ cant predictors 
of quitting were high conﬁ dence levels in quitting at baseline (OR  2.628; p  0.000), 
individuals who had their ﬁ rst cigarettes at least 30 minutes after waking up), ﬁ rst 
cessation attempt, and non-white patients were more likely to quit. CONCLUSIONS:
Smoking cessation program delivered through trained community pharmacists is an
effective approach in reducing smoking. Future research should be conducted to 
compare the effectiveness of pharmacists with other providers of tobacco cessation 
services.
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DOES ADD-ON EVENING DOSE OF FORMOTEROL IMPROVE LUNG
FUNCTION FOR COPD PATIENTS RECEIVING FIXED-DOSE OF 
TIOTROPIUM AND FORMOTEROL?
Imran M, Kotwani A, Chhabra S, Vijayan V
V.P. Chest Institute, Delhi, India
OBJECTIVES: To investigate change in lung function after 24 hours when an evening
dose of formoterol is administered to chronic obstructive pulmonary disease (COPD) 
patients after a morning dose of tiotropium  formoterol. Guidelines recommend 
treatment with mono or combination of long-acting bronchodilators for COPD. 
Recently, daily ﬁ xed-dose combination of tiotropium  formoterol has been used to 
treat COPD. Tiotropium has 24 hour duration of action, whereas the effect of for-
moterol wears off after 12 hours. An add-on evening dose of formoterol may be 
required to retain the additive effect of the combined dose. METHODS: A double-
blind, placebo controlled randomized study of three groups of 20 mild to moderate 
COPD patients was conducted. Group A received morning dose of tiotropium; group
B received tiotropium  formoterol; and group C received tiotropium  formoterol, 
followed by formoetrol inhalation after 12 hours. Lung function was observed at 
baseline, 0.5, 2, and 12 hours after the morning dose. After 12 hours, evening dose
of either placebo (group A and B) or formoterol (group C) was given and parameters 
were recorded at 12:30 and 24 hours. RESULTS: After 30 minutes, tiotropium alone 
improved lung function (FEV1 and FVC) until 24 hours. Tiotropium  formoterol 
improved lung function at 30 minutes. This improvement increased with time till
12:30 hours. After 24 hours, lung function was same as that observed after 12 hours. 
Add-on dose of formoterol after 12 hours did not improve lung function at 24 hours. 
However, add-on evening dose of formoterol enhanced the lung function for mild 
COPD patients (n  5) but not for moderate COPD patients (n  15). CONCLU-
SIONS: Addition of formoterol to tiotropium was beneﬁ cial. No improvement was 
associated with add-on formoterol dose except among patients with mild COPD who
showed signiﬁ cant improvement in lung function. A larger study is needed to replicate 
this ﬁ nding.
